Vertex Pharmaceuticals, Inc.

Some of the best links we picked up around the internet

CMN Weekly (7 February 2025) - Your Weekly CRISPR...

CMN Weekly

Feb. 7, 2025

Some of the best links we picked up around the internet

CMN Weekly (13 December 2024) - Your Weekly CRISPR...

CMN Weekly

Dec. 13, 2024

Some of the best links we picked up around the internet

CMN Weekly (8 November 2024) - Your Weekly CRISPR...

CMN Weekly

Nov. 8, 2024

Some of the best links we picked up around the internet

CMN Weekly (11 October 2024) - Your Weekly CRISPR...

CMN Weekly

Oct. 11, 2024

Some of the best links we picked up around the internet

CMN Weekly (27 September 2024) - Your Weekly...

CMN Weekly

Sep. 27, 2024

Some of the best links we picked up around the internet

CMN Weekly (9 August 2024) - Your Weekly CRISPR...

CMN Weekly

Aug. 9, 2024

Some of the best links we picked up around the internet

CMN Weekly (2 August 2024) - Your Weekly CRISPR...

CMN Weekly

Aug. 2, 2024

Some of the best links we picked up around the internet

Vertex Pharmaceuticals, Inc.

Sickle Cell Disease, SCD, and Transfusion-Dependent Beta-Thalassemia, TDT, (NCT05477563)
Sponsors:
Vertex Pharmaceuticals Incorporated

IND Enabling

Phase I

Phase II

Phase III

Sickle cell disease, SCD, (NCT05951205)
Sponsors:
Vertex Pharmaceuticals Incorporated

IND Enabling

Phase I

Phase II

Phase III

Sickle Cell Disease, SCD, and Transfusion-Dependent Beta-Thalassemia, TDT, (NCT04208529)
Sponsors:
Vertex Pharmaceuticals

IND Enabling

Phase I

Phase II

Phase III

Transfusion-Dependent Beta-Thalassemia, TDT, (NCT05356195)
Sponsors:
Vertex Pharmaceuticals

IND Enabling

Phase I

Phase II

Phase III

Sickle Cell Disease, SCD, (NCT05329649)
Sponsors:
Vertex Pharmaceuticals Incorporated

IND Enabling

Phase I

Phase II

Phase III

Sickle Cell Disease, SCD, (2018-001320-19)
Sponsors:
Vertex Pharmaceuticals Incorporated

IND Enabling

Phase I

Phase II

Phase III

Beta-Thalassemia, BT, (NCT03655678)
Sponsors:
Vertex Pharmaceuticals Inc.

IND Enabling

Phase I

Phase II

Phase III

Sickle Cell Disease, SCD, (NCT03745287)
Sponsors:
Vertex Pharmaceuticals

IND Enabling

Phase I

Phase II

Phase III